Evidence map›Paper›PMID 37776409›Full record

ArticleJournal of medical systems2023

Multi-scale Bottleneck Residual Network for Retinal Vessel Segmentation.

Peipei Li, Zhao Qiu, Yuefu Zhan, Huajing Chen, Sheng Yuan

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of medical systems, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Peipei LiSchool of Computer Science and Technology, Hainan University, Haikou, 570228, China.
Zhao QiuSchool of Computer Science and Technology, Hainan University, Haikou, 570228, China. qiuzhao@hainanu.edu.cn.
Yuefu ZhanAffiliated maternal and child health hospital (Children's hospital) of Hainan medical university/Hainan Women and Children's Medical Center, Haikou, 570312, China. zyfradiology@hainmc.edu.cn.
Huajing ChenHainan Provincial Public Security Department, Haikou, 570203, China.
Sheng YuanSchool of Computer Science and Technology, Hainan University, Haikou, 570228, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Precise segmentation of retinal vessels is crucial for the prevention and diagnosis of ophthalmic diseases. In recent years, deep learning has shown outstanding performance in retinal vessel segmentation. Many scholars are dedicated to studying retinal vessel segmentation methods based on color fundus images, but the amount of research works on Scanning Laser Ophthalmoscopy (SLO) images is very scarce. In addition, existing SLO image segmentation methods still have difficulty in balancing accuracy and model parameters. This paper proposes a SLO image segmentation model based on lightweight U-Net architecture called MBRNet, which solves the problems in the current research through Multi-scale Bottleneck Residual (MBR) module and attention mechanism. Concretely speaking, the MBR module expands the receptive field of the model at a relatively low computational cost and retains more detailed information. Attention Gate (AG) module alleviates the disturbance of noise so that the network can concentrate on vascular characteristics. Experimental results on two public SLO datasets demonstrate that by comparison to existing methods, the MBRNet has better segmentation performance with relatively few parameters.

Indexed as

Image Processing, Computer-AssistedRetinal VesselsFundus OculiHumansOphthalmoscopyAttention mechanismBottleneck residual moduleDeep learningRetinal vessel segmentationScanning Laser Ophthalmoscopy (SLO)U-Net

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.